Glix 13, a new drug acting on glutamatergic pathways in children and animal models of autism spectrum disorders

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Santini, Annamaria Chiara ^a   Pierantoni, Giovanna Maria ^b   Gerlini, Raffaele ^b   Iorio, Rosamaria ^c   Olabinjo, Yinka ^d   Giovane, Alfonso ^c   Di Domenico, Marina ^c   Sogos, Carla ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYX 13; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TETRAPEPTIDE; UNCLASSIFIED DRUG; GLUTAMIC ACID DERIVATIVE; GLYX-13 PEPTIDE; OLIGOPEPTIDE;

AUTISM; BLOOD BRAIN BARRIER; DRUG MECHANISM; GENETIC VARIABILITY; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; REVIEW; ANIMAL; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODEL; GENETICS; METABOLISM;

ANIMALS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODELS, ANIMAL; GENETIC VARIATION; GLUTAMATES; HUMANS; OLIGOPEPTIDES; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84896851651     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/234295     Document Type: Review

References (42)

1. Markova G., Legerstee M., Contingency, imitation, and affect sharing: foundations of infants' social awareness. Developmental Psychology 2006 42 1 132 141 2-s2.0-31644450879 10.1037/0012-1649.42.1.132
2. Feldman R., Parent-infant synchrony: biological foundations and developmental outcomes. Current Directions in Psychological Science 2007 16 6 340 345 2-s2.0-36348957837 10.1111/j.1467-8721.2007.00532.x
3. Meltzoff A. N., The 'like me' framework for recognizing and becoming an intentional agent. Acta Psychologica 2007 124 1 26 43 2-s2.0-33845594295 10.1016/j.actpsy.2006.09.005
4. Kanner L., Autistic disturbances of affective contact. Nervous Child 1943 2 217 250
5. Coyle J. T., Glutamate and schizophrenia: beyond the dopamine hypothesis. Cellular and molecular neurobiology 2006 26 4-6 365 384 2-s2.0-33749074397
6. Kim P. M., Aizawa H., Kim P. S., Huang A. S., Wickramasinghe S. R., Kashani A. H., Barrow R. K., Huganir R. L., Ghosh A., Snyder S. H., Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration. Proceedings of the National Academy of Sciences of the United States of America 2005 102 6 2105 2110 2-s2.0-13844306349 10.1073/pnas.0409723102
7. Martina M., Krasteniakov N. V., Bergeron R., D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons. Journal of Physiology 2003 548 2 411 423 2-s2.0-0037731456 10.1113/jphysiol.2002.037127
8. Baptista V., Varanda W. A., Glycine binding site of the synaptic NMDA receptor in subpostremal NTS neurons. Journal of Neurophysiology 2005 94 1 147 152 2-s2.0-21544436566 10.1152/jn.00927.2004
9. Basu A. C., Tsai G. E., Ma C.-L., Ehmsen J. T., Mustafa A. K., Han L., Jiang Z. I., Benneyworth M. A., Froimowitz M. P., Lange N., Snyder S. H., Bergeron R., Coyle J. T., Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Molecular Psychiatry 2009 14 7 719 727 2-s2.0-67649329655 10.1038/mp.2008.130
10. Labrie V., Lipina T., Roder J. C., Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology 2008 200 2 217 230 10.1007/s00213-008-1196-6
11. Pellis S. M., McKenna M., What do rats find rewarding in play fighting?-an analysis using drug-induced non-playful partners. Behavioural Brain Research 1995 68 1 65 73 2-s2.0-0028903230 10.1016/0166-4328(94)00161-8
12. Ritchie M. E., Belovsky G. E., Sociality of Columbian ground squirrels in relation to their seasonal energy intake. Oecologia 1990 83 4 495 503 2-s2.0-0025664759 10.1007/BF00317200
13. Lakhan S. E., Caro M., Hadzimichalis N., NMDA receptor activity in neuropsychiatric disorders. Front Psychiatry 2013 4 52 10.3389/fpsyt.2013.00052
14. Haring R., Stanton P. K., Scheideler M. A., Moskal J. R., Glycine-like modulation of N-methyl-D-aspartate receptors by a monoclonal antibody that enhances long-term potentiation. Journal of Neurochemistry 1991 57 1 323 332 2-s2.0-0025950425
15. Moskal J. R., Kuo A. G., Weiss C., Wood P. L., O'Connor Hanson A., Kelso S., Harris R. B., Disterhoft J. F., GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator. Neuropharmacology 2005 49 7 1077 1087 2-s2.0-27144543724 10.1016/j.neuropharm. 2005.06.006
16. Liu X.-Q., Paterson A. D., Szatmari P., Genome-wide linkage analyses of quantitative and categorical autism subphenotypes. Biological Psychiatry 2008 64 7 561 570 2-s2.0-50849106386 10.1016/j.biopsych.2008.05.023
17. Zhang A., Shen C.-H., Ma S. Y., Ke Y., Idrissi A. E., Altered expression of Autism-associated genes in the brain of Fragile X mouse model. Biochemical and Biophysical Research Communications 2009 379 4 920 923 2-s2.0-58949089380 10.1016/j.bbrc.2008.12.172
18. Silverman J. L., Tolu S. S., Barkan C. L., Crawley J. N., Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 2010 35 4 976 989 2-s2.0-76749128438 10.1038/npp.2009.201
19. Campbell D. B., Sutcliffe J. S., Ebert P. J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R., Persico A. M., Levitt P., A genetic variant that disrupts MET transcription is associated with autism. Proceedings of the National Academy of Sciences of the United States of America 2006 103 45 16834 16839 2-s2.0-33750962208 10.1073/pnas.0605296103
20. Moy S. S., Nadler J. J., Young N. B., Nonneman R. J., Grossman A. W., Murphy D. L., D'Ercole A. J., Crawley J. N., Magnuson T. R., Lauder J. M., Social approach in genetically engineered mouse lines relevant to autism. Genes, Brain and Behavior 2009 8 2 129 142 2-s2.0-61449217094 10.1111/j.1601-183X. 2008.00452.x
21. Sankoorikal G. M. V., Kaercher K. A., Boon C. J., Lee J. K., Brodkin E. S., A mouse model system for genetic analysis of sociability: C57BL/6J versus BALB/cJ inbred mouse strains. Biological Psychiatry 2006 59 5 415 423 2-s2.0-33344465229 10.1016/j.biopsych.2005.07.026
22. Brodkin E. S., Hagemann A., Nemetski S. M., Silver L. M., Social approach-avoidance behavior of inbred mouse strains towards DBA/2 mice. Brain Research 2004 1002 1-2 151 157 2-s2.0-1342279438 10.1016/j.brainres.2003.12.013
23. Brodkin E. S., BALB/c mice: low sociability and other phenotypes that may be relevant to autism. Behavioural Brain Research 2007 176 1 53 65 2-s2.0-33845319742 10.1016/j.bbr.2006.06.025
24. Panksepp J. B., Jochman K. A., Kim J. U., Koy J. K., Wilson E. D., Chen Q., Wilson C. R., Lahvis G. P., Affiliative behavior, ultrasonic communication and social reward are influenced by genetic variation in adolescent mice. PLoS ONE 2007 2 4, article e351 2-s2.0-35148850474 10.1371/journal.pone.0000351
25. Harmon K. M., Cromwell H. C., Burgdorf J., Moskal J. R., Brudzynski S. M., Kroes R. A., Panksepp J., Rats selectively bred for low levels of 50 kHz ultrasonic vocalizations exhibit alterations in early social motivation. Developmental Psychobiology 2008 50 4 322 331 2-s2.0-48949120027 10.1002/dev.20294
26. Burgdorf J., Kroes R. A., Moskal J. R., Pfaus J. G., Brudzynski S. M., Panksepp J., Ultrasonic vocalizations of rats (Rattus norvegicus) during mating, play, and aggression: behavioral concomitants, relationship to reward, and self-administration of playback. Journal of Comparative Psychology 2008 122 4 357 367 2-s2.0-56749150859 10.1037/a0012889
27. Moskal J. R., Burgdorf J., Kroes R. A., Brudzynski S. M., Panksepp J., A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism. Neuroscience and Biobehavioral Reviews 2011 35 9 1982 1988 2-s2.0-80053108650 10.1016/j.neubiorev.2011.06.006
28. Burgdorf J., Moskal J. R., Brudzynski S. M., Panksepp J., Rats selectively bred for low levels of play-induced 50kHz vocalizations as a model for Autism Spectrum Disorders: a role for NMDA receptors. Behavioural Brain Research 2013 251 18 24 10.1016/j.bbr.2013.04.022
29. Volkmar F. R., Pauls D., Autism. The Lancet 2003 362 9390 1133 1141 2-s2.0-0141528477 10.1016/S0140-6736(03)14471-6
30. Jackson B., The revised diagnostic and statistical manual of the American Psychiatric Association. American Journal of Psychiatry 1970 127 1 65 73 2-s2.0-0014824505
31. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disordersautism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveillance Summaries 2007 56 12 28
32. Baird G., Simonoff E., Pickles A., Chandler S., Loucas T., Meldrum D., Charman T., Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). The Lancet 2006 368 9531 210 215 2-s2.0-33745818375 10.1016/S0140-6736(06) 69041-7
33. Gupta A. R., State M. W., Recent advances in the genetics of autism. Biological Psychiatry 2007 61 4 429 437 2-s2.0-33846614076 10.1016/j.biopsych. 2006.06.020
34. Persico A. M., Bourgeron T., Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends in Neurosciences 2006 29 7 349 358 2-s2.0-33746314832 10.1016/j.tins.2006.05.010
35. Geschwind D. H., Levitt P., Autism spectrum disorders: developmental disconnection syndromes. Current Opinion in Neurobiology 2007 17 1 103 111 2-s2.0-33846921789 10.1016/j.conb.2007.01.009
36. Happé F., Ronald A., Plomin R., Time to give up on a single explanation for autism. Nature Neuroscience 2006 9 10 1218 1220 2-s2.0-33749032127 10.1038/nn1770
37. Adamson L. B., Bakeman R., Deckner D. F., Romski M., Joint engagement and the emergence of language in children with autism and down syndrome. Journal of Autism and Developmental Disorders 2009 39 1 84 96 2-s2.0-57849148934 10.1007/s10803-008-0601-7
38. Dhossche D., Applegate H., Abraham A., Maertens P., Bland L., Bencsath A., Martinez J., Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism. Medical Science Monitor 2002 8 8 PR1 PR6 2-s2.0-0036691555
39. Evins A. E., Amico E., Posever T. A., Toker R., Goff D. C., D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia. Schizophrenia Research 2002 56 1-2 19 23 2-s2.0-0036641749 10.1016/S0920-9964(01)00220-1
40. Posey D. J., Kem D. L., Swiezy N. B., Sweeten T. L., Wiegand R. E., McDougle C. J., A pilot study of D-cycloserine in subjects with autistic disorder. American Journal of Psychiatry 2004 161 11 2115 2117 2-s2.0-7444237570 10.1176/appi.ajp.161.11.2115
41. Priestley T., Marshall G. R., Hill R. G., Kemp J. A., L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective. British Journal of Pharmacology 1998 124 8 1767 1773 2-s2.0-0031815601 10.1038/sj.bjp.0702010
42. Burgdorf J., Zhang X. L., Nicholson K. L., Balster R. L., Leander J. D., Stanton P. K., Gross A. L., Kroes R. A., Moskal J. R., GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology 2013 38 5 729 742 10.1038/npp.2012.246